MedTrace Logo

SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study

NCT04776434 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 723

Last updated 2025-09-23

No results posted yet for this study

Summary

Open label, real-world, prospective, multi-center, single arm, post-market surveillance study of the SELUTION SLR™ (Sustained Limus Release) drug eluting balloon (DEB).

Conditions

Interventions

DEVICE

SELUTION SLR™ (Sustained Limus Release) drug eluting balloon (DEB)

This study will capture data from the use of the SELUTION SLR according to its approved labelling.

Sponsors & Collaborators

  • M.A. Med Alliance S.A.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2024-11-10
Completion
2028-12-31

Countries

  • Argentina
  • Germany
  • Greece
  • Netherlands
  • Singapore
  • Slovakia
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04776434 on ClinicalTrials.gov